News - afatinib, Reproductive, Daysee

Filter

1 to 25 of 90 results

Mike Sullivan appointed president of Avion Pharmaceuticals

Mike Sullivan appointed president of Avion Pharmaceuticals

18-03-2014

Avion Pharmaceuticals, a US-based specialty pharmaceutical company, has announced the promotion of Mike…

Avion PharmaceuticalsBoardroomNovartisPharmaceuticalReproductiveSanofiTher-RxUSAWomen's Health

Dilafor partners with Lee’s Pharmaceutical for tafoxiparin

24-02-2014

Sweden-based Dilafor AB, a Karolinska Development portfolio company, and Lee’s Pharmaceutical Holdings,…

Asia-PacificChinaDilafor ABKarolinska DevelopmentLee's PharmaceuticalLicensingPharmaceuticalReproductivetafoxiparinWomen's Health

Bayer gets “green light” for new transparent low dose contraceptive patch in the EU

Bayer gets “green light” for new transparent low dose contraceptive patch in the EU

14-02-2014

Germany’s Bayer says it has successfully concluded the decentralized European registration procedure…

BayerethinylestradiolEuropegestodenePharmaceuticalRegulationReproductive

Evestra signs research accord with Gedeon Richter

Evestra signs research accord with Gedeon Richter

09-01-2014

Privately-held US firm Evestra says it has signed a collaboration partnership agreement with Hungary’s…

EvestraGedeon RichterLicensingPharmaceuticalReproductiveResearch

Interview: Ferring Pharma’s president Michel Pettigrew on the company’s science-driven growth

Interview: Ferring Pharma’s president Michel Pettigrew on the company’s science-driven growth

18-12-2013

When it comes to being different, privately-owned Ferring Pharma is proud of its culture of enterprise…

BoardroomFerring PharmaceuticalsInterviewsNorthern EuropePharmaceuticalReproductive

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

12-12-2013

Following a public comment period, the US Federal Trade Commission has approved a final order settling…

ActavisGenericsMergers & AcquisitionsNorth AmericaRegulationReproductiveWarner Chilcott

Merck KGaA eighth EPP spin-off to focus on infertility treatment

Merck KGaA eighth EPP spin-off to focus on infertility treatment

02-12-2013

USA-based EMD Serono, one of German drug and chemical group Merck KGaA’s biotechnology subsidiaries,…

BiotechnologyEMD SeronoMerck KGaAMerck SeronoMergers & AcquisitionsReproductiveResearchTocopheRx

Benefits of combined hormonal contraceptives continue to outweigh risks, says EMA/CHMP

Benefits of combined hormonal contraceptives continue to outweigh risks, says EMA/CHMP

23-11-2013

The European Medicines Agency has now completed its review of combined hormonal contraceptives (CHCs),…

EuropePharmaceuticalRegulationReproductiveWomen's Health

New data support Boehringer’s afatinib in Asian and non-Asian lung cancer patients

New data support Boehringer’s afatinib in Asian and non-Asian lung cancer patients

28-10-2013

Data from two pivotal large-scale Phase III registration studies with German independent drug major Boehringer…

afatinibBoehringer IngelheimGilotrifGiotrifOncologyPharmaceuticalResearch

Boehringer’s cancer drug Giotrif gains European marketing authorization

Boehringer’s cancer drug Giotrif gains European marketing authorization

27-09-2013

Boehringer Ingelheim has been granted marketing authorization from the European Commission for Giotrif…

afatinibBoehringer IngelheimEuropeOncologyPharmaceutical

OvaScience slumps 38% on disappointing Augment update

11-09-2013

US fertility treatment specialist OvaScience (Nasdaq: OVAS) saw its shares plummet 38.4% to $8.80 in…

AugmentNorth AmericaOvaSciencePharmaceuticalRegulationReproductive

Apricus Biosciences gains two more approvals for ED drug Vitaros

15-08-2013

USA-based Apricus Biosciences (Nasdaq: APRI) says that the Irish Medicines Board and the Netherlands'…

Apricus BioscienceEuropeMen's HealthPharmaceuticalRegulationReproductiveVitaros

IN FOCUS: Boehringer Ingelheim presents its

IN FOCUS: Boehringer Ingelheim presents its "long and healthy" R&D pipeline

02-08-2013

German family-owned drug major Boehringer Ingelheim presented its major pipeline developments at an R&D…

afatinibBoehringer IngelheimDiabetesEuropeInterviewslinagliptinnintedanibOncologyPharmaceuticalResearchRespiratory and Pulmonaryvolasertib

Germany's Bayer and Boehringer both get CHMP backing

29-07-2013

Among a string of positive recommendations revealed last Friday (July 26) by the European Medicines Agency's…

afatinibBayerBoehringer IngelheimEuropeEyleaGiotrifOncologyOphthalmicsPharmaceuticalRegulation

US FDA approval for Warner Chilcott's new oral contraceptive

26-07-2013

The US Food and Drug Administration have approved the use of a new oral contraceptive from Ireland-based…

ActavisLo Minastrin FeNorth AmericaPharmaceuticalRegulationReproductiveWarner Chilcott

US FDA approves Boehringer Ingelheim's first cancer drug

15-07-2013

In what the family-owned German drug major Boehringer Ingelheim hopes is just the first drug to come…

afatinibBiotechnologyBoehringer IngelheimGilotrifNorth AmericaOncologyPharmaceuticalQiagenRegulation

Vivus partners with Menarini for European and Australia/NZ marketing of ED drug

09-07-2013

US drugmaker Vivus (Nasdaq: VVUS) has entered into a license and commercialization agreement and a supply…

Asia-PacificavanafilEuropeLicensingMarkets & MarketingMen's HealthMenariniPharmaceuticalReproductiveSpedraVivus

Generic launches by Mylan, Stada Arz and Dr Reddy's

27-06-2013

US copy drugs maker Mylan (NYSE: MYL) has launched norethindrone tablets USP, 0.35 the generic version…

Dr Reddy's LaboratoriesEuropeGenericsLamictal XRMarkets & MarketingMen's HealthMicronorMylan LaboratoriesNeurologicalNorth AmericaReproductiveSTADA ArzneimittelViagra

European approval for Vivus' ED drug Spedra

27-06-2013

The European Commission yesterday (June 26) has granted marketing authorization for USA-based Vivus'…

avanafilEuropeMen's HealthPharmaceuticalRegulationReproductiveSpedraVivus

Teva and Actavis debut generic Viagra in Europe

24-06-2013

The patent on Viagra (sildenafil) expired last Friday (June 21) in the UK and some other European countries,…

ActavisEuropeGenericsMarkets & MarketingMen's HealthReproductivesildenafilTeva Pharmaceutical IndustriesViagra

FDA approves Plan B One-Step emergency contraceptive for OTC use by women of child-bearing potential

21-06-2013

The US Food and Drug Administration has approved the use of Plan B One-Step (levonorgestrel), from Israel-headquartered…

North AmericaPharmaceuticalPlan B One-StepRegulationReproductiveTeva Pharmaceutical IndustriesWomen's Health

Actavis confirms patent challenge on Bayer's Safyral

06-06-2013

USA-based generics major Actavis (NYSE: ACT) yesterday (June 5) confirmed that it has filed an Abbreviated…

ActavisBayerGenericsPatentsRegulationReproductiveSafyralWomen's Health

US FDA grants priority review for Janssen's simeprevir, accepts Biogen Idec's Eloctate and Actavis' progestin-only patch filing

13-05-2013

The US Food and Drug Administration has granted Priority Review to the New Drug Application for simeprevir…

ActavisAnti-viralsBiogen IdecBiotechnologyEloctateJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationReproductivesimeprevirTMC435

FDA approves Raptor's Procysbi for rare genetic condition; and Plan B One-Step

01-05-2013

US drugmaker Raptor Pharmaceuticals (Nasdaq: RPTP) saw its share price rise 7.5% to $7.06 in mid-afternoon…

North AmericaPharmaceuticalPlan B One-StepProcysbiRaptor PharmaceuticalsRare diseasesRegulationReproductiveTeva Pharmaceutical IndustriesWomen's Health

1 to 25 of 90 results

Back to top